Literature DB >> 31147242

Efficiency of sirolimus delivery to the skin is dependent on administration route and formulation.

Kazuko Kitayama1, Shinichiro Maeda2, Ayumi Nakamura3, Ichiro Katayama1, Mari Wataya-Kaneda4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31147242     DOI： 10.1016/j.jdermsci.2019.05.002

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  2 in total

1.  Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial.

Authors:  Mari Wataya-Kaneda; Hiroshi Nagai; Yuuki Ohno; Hiroo Yokozeki; Yasuyuki Fujita; Hironori Niizeki; Kazue Yoshida; Masaaki Ogai; Yuichi Yoshida; Akihiko Asahina; Kazuyoshi Fukai; Chiharu Tateishi; Izumi Hamada; Tatsuro Takahata; Kenji Shimizu; Shigeki Shimasaki; Hiroyuki Murota
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-08

2.  Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.

Authors:  Sreedevi Boggarapu; Steven L Roberds; JoAnne Nakagawa; Eric Beresford
Journal:  Orphanet J Rare Dis       Date:  2022-09-14       Impact factor: 4.303
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.